Omada Health (NASDAQ:OMDA) CAO Craig Gracey Sells 644 Shares of Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 644 shares of Omada Health stock in a transaction dated Wednesday, September 9th. The stock was sold at an average price of $21.73, for a total value of $13,994.12. Following the sale, the chief accounting officer directly owned 14,412 shares in the company, valued at approximately $313,172.76. The trade was a 4.28% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Craig Gracey also recently made the following trade(s):

• On Monday, August 10th, Craig Gracey sold 1,042 shares of Omada Health stock. The shares were sold at an average price of $25.00, for a total value of $26,050.00.
• On Wednesday, July 1st, Craig Gracey sold 637 shares of Omada Health stock. The shares were sold at an average price of $23.00, for a total value of $14,651.00.
• On Tuesday, June 30th, Craig Gracey sold 405 shares of Omada Health stock. The stock was sold at an average price of $22.00, for a total value of $8,910.00.
• On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $21.00, for a total value of $43,743.00.
• On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The shares were sold at an average price of $20.00, for a total value of $41,680.00.
• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $19.01, for a total transaction of $39,597.83.
• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total transaction of $37,494.00.

Omada Health Price Performance

OMDA opened at $19.66 on Friday. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $26.92. The stock has a market capitalization of $1.20 billion, a PE ratio of 393.20 and a beta of 1.86. The firm’s fifty day moving average price is $22.63 and its 200 day moving average price is $17.92.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.10. The company had revenue of $87.83 million during the quarter, compared to analyst estimates of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. On average, equities research analysts forecast that Omada Health, Inc. will post 0.09 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Omada Health

Several institutional investors have recently modified their holdings of OMDA. Perceptive Advisors LLC bought a new stake in Omada Health in the 2nd quarter valued at about $44,402,000. Millennium Management LLC grew its position in Omada Health by 1,195.0% in the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock worth $35,855,000 after purchasing an additional 2,096,705 shares during the last quarter. BlackRock Inc. acquired a new stake in shares of Omada Health in the second quarter valued at approximately $48,775,000. Loomis Sayles & Co. L P boosted its position in shares of Omada Health by 23.0% during the fourth quarter. Loomis Sayles & Co. L P now owns 1,855,721 shares of the company’s stock worth $29,283,000 after buying an additional 346,588 shares during the period. Finally, Jefferies Financial Group Inc. bought a new position in Omada Health in the 4th quarter worth approximately $16,948,000.

Key Stories Impacting Omada Health

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Analyst support remains strong: BTIG Research reaffirmed its “buy” rating and set a $35 price target, while Needham & Company also maintained a “buy” rating with a $28 target. These targets imply significant potential upside and reinforce confidence in Omada’s growth outlook.
• Positive Sentiment: Investor Day could provide new growth targets: Omada held its inaugural Investor Day and planned to present updated long-term financial targets. More ambitious revenue, profitability, or membership goals could improve investor confidence if management’s outlook exceeds current expectations. Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day
• Neutral Sentiment: Investor Day transcript available: The transcript may offer additional detail on Omada’s strategy and financial targets, but the supplied report does not identify specific changes that would immediately alter earnings expectations. Omada Health Analyst/Investor Day Transcript
• Negative Sentiment: Chief accounting officer sold shares: CAO Craig Gracey sold 644 shares for approximately $14,000, reducing his direct ownership by 4.28%. The relatively small transaction is not necessarily a sign of deteriorating fundamentals, but insider selling can create short-term negative sentiment. SEC Insider Transaction Filing

Wall Street Analysts Forecast Growth

OMDA has been the topic of several research reports. Citizens Jmp upped their price target on Omada Health from $27.00 to $32.00 and gave the company a “market outperform” rating in a research report on Friday, August 14th. Barclays boosted their target price on shares of Omada Health from $25.00 to $27.00 and gave the company an “overweight” rating in a research note on Friday. Weiss Ratings upgraded shares of Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a research report on Tuesday, August 11th. JPMorgan Chase & Co. lifted their price target on shares of Omada Health from $26.00 to $30.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Finally, Morgan Stanley reissued an “overweight” rating and issued a $30.00 target price on shares of Omada Health in a report on Monday, June 22nd. Eleven equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $26.67.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.